Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
ID: 356904Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for cooperative agreements to establish a Clinical Coordinating Center (CCC) for multi-site, investigator-initiated clinical trials focused on the effects of natural products, such as botanicals and dietary supplements. Applicants are required to develop a comprehensive scientific and operational plan for the clinical trial, including project management, participant recruitment, and performance milestones, while also submitting a companion Data Coordinating Center (DCC) application. This initiative aims to generate robust clinical data to inform integrative health approaches and public health strategies, with applications opening on January 20, 2025, and closing on July 14, 2026. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-312.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Center for Complementary and Integrative Health (NCCIH), is issuing a funding opportunity for cooperative agreements to support multi-site, investigator-initiated clinical trials studying the effects of natural products. This funding mechanism, designated as UG3/UH3, aims to establish a Clinical Coordinating Center (CCC) and requires a companion Data Coordinating Center (DCC) application. The trials should focus on areas such as nutritional regimens and dietary supplements with promising preliminary evidence. Eligible applicants include higher education institutions, nonprofits, and government entities, with funding available contingent on appropriations and the quality of applications submitted. Rigor in trial design, participant recruitment, and diverse perspectives are emphasized, as well as adherence to regulatory standards such as those from the FDA. Key dates include an open application date starting January 20, 2025, with an expiration on July 15, 2026. The overall aim is to generate robust clinical data on the efficacy of natural products to inform integrative health approaches and public health strategies.
    Similar Opportunities
    Loading similar opportunities...